COMMUNIQUÉS West-GlobeNewswire

Outset Medical Names Derick Elliott as Executive Vice President of Commercial
06/04/2026
SAN JOSE, Calif., April 06, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and [...]
Silo Pharma Receives European Patent Allowance for Licensed Novel PTSD Prevention Therapy
06/04/2026
EPO Greenlights Claims Covering Preventative use of therapy targeting 5-HT4 Pathway and Expands Silo Pharma IP Portfolio SARASOTA, FL, April 06, 2026 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “ [...]
Glyco Harmony Drops Claims Evaluated: Explore the Official Gluco Harmony Glycogen Support Website Facts
06/04/2026
A 2026 informational overview of Glyco Harmony blood sugar support drops, chromium picolinate and proprietary blend ingredient disclosures, liquid supplement formulation details, and what the official Glyco Harmony [...]
Neuronetics Announces Chief Financial Officer Transition
06/04/2026
Reaffirms Fiscal Year 2026 Financial Guidance MALVERN, Pa., April 06, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company”), a medical technology company focused on designing, developing, and [...]
Metabo Drops Claims Evaluated: Recent Investigation Into MetaboDrops Official Website Announcement
06/04/2026
A 2026 informational overview of Metabo Drops coffee metabolism drop marketing claims, proprietary blend label disclosures, ingredient dosage research context, pricing structure, 60-day guarantee terms, and what men and [...]
Organogenesis Announces Successful FDA Meeting and Plan to File BLA for ReNu® for Knee Osteoarthritis Pain
06/04/2026
Clinical Development Program Appropriate for Rolling BLA Submission Expected by the End of 2025 CANTON, Mass., April 06, 2026 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative [...]
Avicanna Announces Changes to its Board of Directors
06/04/2026
TORONTO, April 06, 2026 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or the “ Company ”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and [...]
Biodesix Announces AACR 2026 Posters and Presentations, Highlighting Novel Diagnostic Test Discovery & Pipeline Development
06/04/2026
Includes novel proteomic and genomic approaches to oncology therapeutic selection, response monitoring, and Molecular Residual Disease (MRD) testing LOUISVILLE, Colo., April 06, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. ( [...]
DIBS AI Unveils Version 9.0 Platform Suite to Streamline Orthodontic Workflows
06/04/2026
Three AI-driven platforms improve efficiency, predictability, and turnaround times—delivered at $165 per case AMERICAN FORK, Utah, April 06, 2026 (GLOBE NEWSWIRE) -- DIBS AI ® , a division of OrthoSelect, announces the [...]
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
06/04/2026
FLORHAM PARK, N.J., April 06, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on commercializing and developing novel treatments for gastrointestinal (GI) [...]
Axe Compute Names Kyle Okamoto President, Adding Deep Infrastructure Systems Expertise to Executive Team
06/04/2026
Okamoto, who helped scale Aethir's decentralized GPU network to 200+ global locations, will lead enterprise growth strategy and execution at Axe Compute PITTSBURGH, April 06, 2026 (GLOBE NEWSWIRE) -- Axe Compute (Nasdaq [...]
Verrica Pharmaceuticals to Participate in the 25th Annual Needham Virtual Healthcare Conference
06/04/2026
WEST CHESTER, Pa., April 06, 2026 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a therapeutics company developing and commercializing medications for the treatment of dermatological [...]
Avalyn Appoints Jon Congleton, Seasoned Biopharmaceutical Executive, to its Board of Directors
06/04/2026
BOSTON, April 06, 2026 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., (“Avalyn” or the “Company”), a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the treatment paradigm of serious, rare [...]
Aveanna Healthcare Announces Second Annual Aveanna Cares Month of Service
06/04/2026
ATLANTA, April 06, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare (NASDAQ: AVAH ) today announced the second year of Aveanna Cares, the company’s month-long, team-based volunteer initiative dedicated to giving back to the [...]
New LockeT Data Accepted in Leading Electrophysiology Journal
06/04/2026
FORT MILL, S.C., April 06, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK) (“VTAK” or the “Company”) today announced that the manuscript titled “Safety and Efficacy of LockeT Suture Retention [...]
Extendicare Announces Timing of 2026 First Quarter Results and Conference Call
06/04/2026
MARKHAM, Ontario, April 06, 2026 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it plans to release its financial results for the first quarter of 2026 after market [...]
Inspire Medical Systems, Inc. to Report First Quarter 2026 Financial Results on May 4, 2026
06/04/2026
MINNEAPOLIS, April 06, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the first quarter 2026 after the close of trading on Monday, May 4. Inspire’s [...]
Geron to Participate in the 25th Annual Needham Virtual Healthcare Conference
06/04/2026
FOSTER CITY, Calif., April 06, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that [...]
Scienture Provides Annual Shareholder Update, Outlining Significant Progress and Strategic Priorities for the Year Ahead
06/04/2026
COMMACK, NY, April 06, 2026 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) (“Scienture”) a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to [...]

Pages